Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07144644 · ClinicalTrials.gov registry record
2311 TURGOR Study -Surgical Efficiency and Postoperative Corneal Clarity With Near Physiologic vs High IOP Settings
A clinical trial, sponsored by Research Insight.
- Completed
- Registry status
- 81
- Enrollment target
NCT07144644: Completed study, sponsored by Research Insight.
NCT07144644 is a clinical trial that has completed, run by Research Insight. The registered enrollment target is 81 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07144644 has completed, sponsored by Research Insight.
- COMPLETED
- Registry status
- 81 participants
- Enrollment target
Study Summary
The study aims to investigate whether adjusting intraocular pressure (IOP) settings to near physiologic levels during cataract surgery could potentially lead to better surgical outcomes, particularly in terms of corneal clarity in the post-operative period.
Primary Outcome
Measurement by Pentacam
Interventions
- DEVICE Adjusting intraocular pressure (IOP) settings
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2024-07-26 |
| Est. Completion | 2025-08-06 |
What the finished NCT07144644 record still lists
NCT07144644 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 81 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Adjusting intraocular pressure (IOP) settings is the first listed.
NCT07144644 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07144644 about?
NCT07144644 is a clinical study titled "2311 TURGOR Study -Surgical Efficiency and Postoperative Corneal Clarity With Near Physiologic vs High IOP Settings". The study aims to investigate whether adjusting intraocular pressure (IOP) settings to near physiologic levels during cataract surgery could potentially lead to better surgical outcomes, particularly in terms of corneal clarity in the post-operative period.
What is the current status of trial NCT07144644?
This trial is currently completed. The enrollment target is 81 participants. The study started on 2024-07-26. Estimated completion is 2025-08-06.
What interventions are being tested in trial NCT07144644?
The interventions under investigation include: Adjusting intraocular pressure (IOP) settings (DEVICE).
Who is sponsoring clinical trial NCT07144644?
This trial is sponsored by Research Insight, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI